441 related articles for article (PubMed ID: 33034398)
1. A role for quercetin in coronavirus disease 2019 (COVID-19).
Derosa G; Maffioli P; D'Angelo A; Di Pierro F
Phytother Res; 2021 Mar; 35(3):1230-1236. PubMed ID: 33034398
[TBL] [Abstract][Full Text] [Related]
2. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
3. Quercetin Phytosome® as a potential candidate for managing COVID-19.
DI Pierro F; Khan A; Bertuccioli A; Maffioli P; Derosa G; Khan S; Khan BA; Nigar R; Ujjan I; Devrajani BR
Minerva Gastroenterol (Torino); 2021 Jun; 67(2):190-195. PubMed ID: 33016666
[TBL] [Abstract][Full Text] [Related]
4. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
6. Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients.
Ghanbari R; Teimoori A; Sadeghi A; Mohamadkhani A; Rezasoltani S; Asadi E; Jouyban A; Sumner SC
Future Microbiol; 2020 Dec; 15():1747-1758. PubMed ID: 33404263
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV).
Bano S; Hameed A; Al-Rashida M; Iftikhar S; Iqbal J
Curr Med Chem; 2021; 28(22):4484-4498. PubMed ID: 33109027
[TBL] [Abstract][Full Text] [Related]
8. Polyphenolic Compounds Isolated from Marine Algae Attenuate the Replication of SARS-CoV-2 in the Host Cell through a Multi-Target Approach of 3CL
Nagahawatta DP; Liyanage NM; Je JG; Jayawardhana HHACK; Jayawardena TU; Jeong SH; Kwon HJ; Choi CS; Jeon YJ
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547933
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
[TBL] [Abstract][Full Text] [Related]
10. Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.
Swargiary A; Mahmud S; Saleh MA
J Biomol Struct Dyn; 2022 Mar; 40(5):2067-2081. PubMed ID: 33089730
[TBL] [Abstract][Full Text] [Related]
11. DockCoV2: a drug database against SARS-CoV-2.
Chen TF; Chang YC; Hsiao Y; Lee KH; Hsiao YC; Lin YH; Tu YE; Huang HC; Chen CY; Juan HF
Nucleic Acids Res; 2021 Jan; 49(D1):D1152-D1159. PubMed ID: 33035337
[TBL] [Abstract][Full Text] [Related]
12. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.
Kilianski A; Mielech AM; Deng X; Baker SC
J Virol; 2013 Nov; 87(21):11955-62. PubMed ID: 23986593
[TBL] [Abstract][Full Text] [Related]
13.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
14. Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.
Oso BJ; Olaoye IF; Omeike SO
Arch Razi Inst; 2021; 76(3):453-459. PubMed ID: 34824739
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2.
Saakre M; Mathew D; Ravisankar V
Beni Suef Univ J Basic Appl Sci; 2021; 10(1):21. PubMed ID: 33782651
[TBL] [Abstract][Full Text] [Related]
16. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Chowdhury T; Roymahapatra G; Mandal SM
Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
[TBL] [Abstract][Full Text] [Related]
17. All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity.
Morita T; Miyakawa K; Jeremiah SS; Yamaoka Y; Sada M; Kuniyoshi T; Yang J; Kimura H; Ryo A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452533
[TBL] [Abstract][Full Text] [Related]
18. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M
Potshangbam AM; Nongdam P; Kumar AK; Rathore RS
Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301
[TBL] [Abstract][Full Text] [Related]
19. Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M
Mangiavacchi F; Botwina P; Menichetti E; Bagnoli L; Rosati O; Marini F; Fonseca SF; Abenante L; Alves D; Dabrowska A; Kula-Pacurar A; Ortega-Alarcon D; Jimenez-Alesanco A; Ceballos-Laita L; Vega S; Rizzuti B; Abian O; Lenardão EJ; Velazquez-Campoy A; Pyrc K; Sancineto L; Santi C
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208928
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
Shah A; Patel V; Parmar B
Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
